Association of peripheral insulin resistance and other markers of type 2 diabetes mellitus with brain amyloid deposition in healthy individuals at risk of dementia
Manuscript Number:
20-0145R2
Author(s):
Anette Hall, Nina Kemppainen, Miia Kivipelto, Francesca Mangialasche, Patrizia Mecocci, Tiia Ngandu, Timo Pekkala, Juha O. Rinne, Hilkka Soininen, Alina Solomon, Jaakko Tuomilehto
Disclosures
Anette Hall
Nothing to Disclose
Nina Kemppainen
Nothing to Disclose
Miia Kivipelto
Consulting Fees:
Combinostics, Biogen
Grants
Agency:
Janssen
Dates:
2020
Francesca Mangialasche
Nothing to Disclose
Patrizia Mecocci
Nothing to Disclose
Tiia Ngandu
Nothing to Disclose
Timo Pekkala
Equity:
Small positions in publicly traded companies that do not operate in the health care or pharmaceuticals sectors. (Amazon, Alphabet, Twitter, Shell, Sampo, Berkshire).
Juha O. Rinne
Nothing to Disclose
Hilkka Soininen
Consulting Fees:
Fees for advisory boards from ACImmune and Novo Nordisk.